Adamas Orphaned for Parkinson Cure $ADMS $XHS
FDA has granted Adamas Pharmaceuticals, Inc. Orphan drug staus to the firm’s ADS-5102 for the treatment of Levodopa-induced Dyskinesia associated with Parkinson’s disease. View the full release here.
Adamas Orphaned for Parkinson Cure $ADMS $XHS Read More »